Lista de obras -

A boceprevir failure in a patient infected with HCV genotype 1g: importance and limitations of virus genotyping prior to HCV protease-inhibitor-based therapy

artículo científico publicado en 2013

A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen

artículo científico publicado en 2011

A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapte

artículo científico publicado en 2005

Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen

artículo científico publicado en 2013

Anti-phosphatidylserine/prothrombin antibodies: an additional diagnostic marker for APS?

artículo científico publicado en 2013

Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE).

artículo científico

Contribution of transgender sex workers to the complexity of the HIV-1 epidemic in the metropolitan area of Milan

scientific article published on 03 January 2020

Geographical reconstruction of the SARS-CoV-2 outbreak in Lombardy (Italy) during the early phase

artículo científico publicado en 2020

HIV-1 A1 Subtype Epidemic in Italy Originated from Africa and Eastern Europe and Shows a High Frequency of Transmission Chains Involving Intravenous Drug Users

artículo científico publicado en 2016

HIV-1 subtype F1 epidemiological networks among Italian heterosexual males are associated with introduction events from South America ⬇️

artículo científico publicado en 2012

Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome

artículo científico publicado en 2014

Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.

artículo científico publicado en 2018

Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients

artículo científico publicado en 2014

Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens

artículo científico publicado en 2017

Interpretation of genotypic HIV-1 resistance to darunavir and virological response: validation of available systems and of a new score

artículo científico publicado en 2011

Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia

artículo científico publicado en 2010

Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies

artículo científico publicado en 2017

Multidrug-resistant HIV viral rebound during early syphilis: a case report

scientific article published on 07 April 2020

No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy

artículo científico

Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection

article

Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy

artículo científico publicado en 2020

Overlapping structure of hepatitis B virus (HBV) genome and immune selection pressure are critical forces modulating HBV evolution

artículo científico publicado en 2012

Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group

artículo científico publicado en 2010

Phylogenetic analysis provides evidence of interactions between Italian heterosexual and South American homosexual males as the main source of national HIV-1 subtype C epidemics

artículo científico publicado en 2014

Relapse of Kaposi's Sarcoma and HHV-8 viremia in an HIV-infected patient switching from protease inhibitor to integrase inhibitor-based antiretroviral therapy

artículo científico publicado en 2015

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

artículo científico publicado en 2018

Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development

artículo científico publicado en 2011

Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection

artículo científico publicado en 2014

Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing

artículo científico publicado en 2012

The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing

artículo científico publicado en 2013

The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes

artículo científico publicado en 2008

Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies

artículo científico publicado en 2007

Transmission of resistant HIV type 1 variants and epidemiological chains in Italian newly diagnosed individuals

artículo científico publicado en 2011

Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure

scientific article published on 30 October 2020

Lista de obras de

A boceprevir failure in a patient infected with HCV genotype 1g: importance and limitations of virus genotyping prior to HCV protease-inhibitor-based therapy

A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen

A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapte

Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen

Anti-phosphatidylserine/prothrombin antibodies: an additional diagnostic marker for APS?

Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE).

Contribution of transgender sex workers to the complexity of the HIV-1 epidemic in the metropolitan area of Milan

Geographical reconstruction of the SARS-CoV-2 outbreak in Lombardy (Italy) during the early phase

HIV-1 A1 Subtype Epidemic in Italy Originated from Africa and Eastern Europe and Shows a High Frequency of Transmission Chains Involving Intravenous Drug Users

HIV-1 subtype F1 epidemiological networks among Italian heterosexual males are associated with introduction events from South America ⬇️

Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome

Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.

Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients

Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens

Interpretation of genotypic HIV-1 resistance to darunavir and virological response: validation of available systems and of a new score

Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia

Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies

Multidrug-resistant HIV viral rebound during early syphilis: a case report

No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy

Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection

Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy

Overlapping structure of hepatitis B virus (HBV) genome and immune selection pressure are critical forces modulating HBV evolution

Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group

Phylogenetic analysis provides evidence of interactions between Italian heterosexual and South American homosexual males as the main source of national HIV-1 subtype C epidemics

Relapse of Kaposi's Sarcoma and HHV-8 viremia in an HIV-infected patient switching from protease inhibitor to integrase inhibitor-based antiretroviral therapy

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development

Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection

Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing

The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing

The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes

Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies

Transmission of resistant HIV type 1 variants and epidemiological chains in Italian newly diagnosed individuals

Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure